-
EP4406616
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4406616
| EP4406616 - SUBSTITUTED PYRAZOLO(1,5-A)PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS [Right-click to bookmark this link] | Status | The application has been published Status updated on 27.06.2024 Database last updated on 02.11.2024 | Most recent event Tooltip | 03.10.2024 | Publication of search report | published on 06.11.2024 [2024/45] | 03.10.2024 | Change - classification | published on 06.11.2024 [2024/45] | 03.10.2024 | Change - classification | published on 06.11.2024 [2024/45] | Applicant(s) | For all designated states Bial-R&D Investments, S.A. Àvenida da Siderurgia Nacional 4745-457 Coronado (S. Romão e S. Mamede) / PT | [2024/31] | Inventor(s) | 01 /
SKERLJ, Renato West Newton, MA 02465 / US | 02 /
LANSBURY, Peter Brookline, MA 02445 / US | 03 /
GOOD, Andrew Wallingford, CT 06492 / US | 04 /
BOURQUE, Elyse Bellingham, WA 98226 / US | [2024/31] | Representative(s) | Wilson, Justin Scott Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [2024/31] | Application number, filing date | 24166780.7 | 06.11.2015 | [2024/31] | Priority number, date | US201462076062P | 06.11.2014 Original published format: US 201462076062 P | [2024/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4406616 | Date: | 31.07.2024 | Language: | EN | [2024/31] | Type: | A3 Search report | No.: | EP4406616 | Date: | 06.11.2024 | Language: | EN | [2024/45] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 07.10.2024 | Classification | IPC: | C07D487/04, A61K31/519, A61P25/16, A61P27/06, A61P3/10, A61P13/12, A61P25/24, A61P25/28, A61P25/08, A61P25/18, A61P25/22, A61P43/00 | [2024/45] | CPC: |
C07D487/04 (EP,IL,KR,US);
A61K31/519 (IL,KR);
A61P13/12 (EP,IL);
A61P25/08 (EP,IL);
A61P25/16 (EP,IL);
A61P25/18 (EP,IL);
A61P25/22 (EP,IL);
A61P25/24 (EP,IL);
A61P25/28 (EP,IL);
A61P27/06 (EP,IL);
A61P3/10 (EP,IL);
A61P35/00 (EP,IL);
A61P43/00 (EP,IL)
(-)
|
| Former IPC [2024/31] | A61P43/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/31] | Title | German: | SUBSTITUIERTE PYRAZOLO(1,5-A)PYRIMIDINE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON MEDIZINISCHEN ERKRANKUNGEN | [2024/31] | English: | SUBSTITUTED PYRAZOLO(1,5-A)PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | [2024/31] | French: | PYRAZOLO(1,5-A)PYRIMIDINES SUBSTITUEES ET LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES MEDICAUX | [2024/31] | Parent application(s) Tooltip | EP15857508.4 / EP3215511 | Fees paid | Renewal fee | 27.03.2024 | Renewal fee patent year 03 | 27.03.2024 | Renewal fee patent year 04 | 27.03.2024 | Renewal fee patent year 05 | 27.03.2024 | Renewal fee patent year 06 | 27.03.2024 | Renewal fee patent year 07 | 27.03.2024 | Renewal fee patent year 08 | 27.03.2024 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||